Is this normal aging, or could it indicate dementia? According to experts, the answer is often reassuring, but context and patterns matter.

Lithium-a decades-old treatment for bipolar disorder-may hold potential neuroprotective benefits beyond mood stabilization.

A clinical trial suggests that low-dose lithium may slow the decline of verbal memory in older adults with mild cognitive impairment and amyloid-beta.

Lithium—a decades-old treatment for bipolar disorder—may hold potential neuroprotective benefits beyond mood stabilization.

For too long, the promise of personalized therapies has been tantalizingly close, yet frustratingly out of reach for ...

Researchers have built a blood-based “clock” that estimates when Alzheimer’s symptoms will likely begin, potentially years before any memory loss appears. The model, validated in two major ...

But scientists are now warning that some commonly used drugs may have an unexpected effect on the brain, especially in older ...

Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.

Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to ...

In the hunt to ward off dementia, research out of the UK this week looked to assess whether existing drugs could be repurposed to fight the memory-robbing illness.

The following guide offers a detailed overview of several classes of medications that research links to a higher risk of dementia. You will find what these drugs treat, the evidence connecting them to ...

Nial Wheate in the past has received funding from the ACT Cancer Council, Tenovus Scotland, Medical Research Scotland, Scottish Crucible, and the Scottish Universities Life Sciences Alliance. He is a ...